PRODUCTS

Next-Generation Sequencing (RUO)

PRODUCTS

Next-Generation
Sequencing
(RUO)

Determine clonality & track clonal populations with the same reagents & workflow

NGS is a powerful, high-throughput DNA sequencing technology that allows for massively parallel sequencing of millions of DNA fragments in a single sequencing run. NGS is revolutionizing modern science and healthcare.

VIEW AVAILABLE PRODUCTS ⟶

Determine clonality & track clonal populations with the same reagents & workflow

NGS is a powerful, high-throughput DNA sequencing technology that allows for massively parallel sequencing of millions of DNA fragments in a single sequencing run. NGS is revolutionizing modern science and healthcare.

VIEW AVAILABLE PRODUCTS ⟶

PATIENT INFORMATION

Why it Matters

Everyone’s disease is different.

The genetics of each individual is different. The results from these NGS tests provide important insights.

TECHNICAL INFORMATION

How it Works

Detects clonal gene rearrangements.

Our NGS kits are used to detect clonal gene rearrangements, somatic hypermutations, and for the study of MRD. These RUO products that are used extensively all over the world.

PATIENT INFORMATION

Why it Matters

Everyone’s disease is different.

The genetics of each individual is different. The results from these NGS tests provide important insights.

TECHNICAL INFORMATION

How it Works

Detects clonal gene rearrangements.

Our NGS kits are used to detect clonal gene rearrangements, somatic hypermutations, and for the study of MRD. These RUO products that are used extensively all over the world.

Illumina^{^®}

Next-Generation Sequencing

Sanger sequencing methods represent the most popular in a range of ‘first-generation’ nucleic acid sequencing technologies. Newer platforms such as the Illumina MiSeq^®, which leverage massively parallel sequencing approaches, are often referred to as Next-Generation Sequencing (NGS). NGS technologies can use various combination strategies of template preparation, sequencing, imaging, and bioinformatics for genome alignment and assembly.

Illumina^{^®}

Next-Generation Sequencing

Sanger sequencing methods represent the most popular in a range of ‘first-generation’ nucleic acid sequencing technologies. Newer platforms such as the Illumina MiSeq^®, which leverage massively parallel sequencing approaches, are often referred to as Next-Generation Sequencing (NGS). NGS technologies can use various combination strategies of template preparation, sequencing, imaging, and bioinformatics for genome alignment and assembly.

RUO

Invivoscribe offers an array of Research Use Only assays for use on the Illumina MiSeq^®.

The LymphoTrack RUO Assays, developed for use with the leading NGS platforms, include optimized multiplex PCR master mixes with primers incorporating both platform specific adapters, and specimen tracking sequencing identification tags for single step workflow. A comprehensive bioinformatics software package is provided free of charge with purchase; enabling you to identify the DNA sequence, clonal prevalence, V-J family identity for each gene rearrangement, and with the IGH V Leader or IGH FR1 assay, the extent of IGHV somatic hypermutation (SHM).

VIEW AVAILABLE PRODUCTS ⟶

RUO

Invivoscribe offers an array of Research Use Only assays for use on the Illumina MiSeq^®.

The LymphoTrack RUO Assays, developed for use with the leading NGS platforms, include optimized multiplex PCR master mixes with primers incorporating both platform specific adapters, and specimen tracking sequencing identification tags for single step workflow. A comprehensive bioinformatics software package is provided free of charge with purchase; enabling you to identify the DNA sequence, clonal prevalence, V-J family identity for each gene rearrangement, and with the IGH V Leader or IGH FR1 assay, the extent of IGHV somatic hypermutation (SHM).

VIEW AVAILABLE PRODUCTS ⟶

Thermo Fisher^{^®}

Next-Generation Sequencing

Sanger sequencing methods represent the most popular in a range of ‘first-generation’ nucleic acid sequencing technologies. Newer platforms such as the Ion S5^TM and Ion PGM^TM, leverage massively parallel sequencing approaches, are often referred to as Next-Generation Sequencing (NGS). NGS technologies can use various combination strategies of template preparation, sequencing, imaging, and bioinformatics for genome alignment and assembly.

Thermo Fisher^{^®}

Next-Generation Sequencing

Sanger sequencing methods represent the most popular in a range of ‘first-generation’ nucleic acid sequencing technologies. Newer platforms such as the Ion S5TM and Ion PGMTM, leverage massively parallel sequencing approaches, are often referred to as Next-Generation Sequencing (NGS). NGS technologies can use various combination strategies of template preparation, sequencing, imaging, and bioinformatics for genome alignment and assembly.

RUO

Invivoscribe offers an array of Research Use Only assays for use on the Ion S5^™ and PGM^™.

RUO assays, developed for use with the Ion S5™/PGM™ platforms, include optimized multiplex PCR master mixes with primers incorporating both platform specific adapters, and specimen tracking sequencing identification tags for single step workflow. A comprehensive bioinformatics software package is provided free of charge with purchase; enabling you to identify the DNA sequence, clonal prevalence, V-J family identity for each gene rearrangement, and with the IGH FR1 assay, the extent of IGHV somatic hypermutation (SHM).

VIEW AVAILABLE PRODUCTS ⟶

RUO

Invivoscribe offers an array of Research Use Only assays for use on the Ion S5^™ and PGM^™.

RUO assays, developed for use with the Ion S5™/PGM™ platforms, include optimized multiplex PCR master mixes with primers incorporating both platform specific adapters, and specimen tracking sequencing identification tags for single step workflow. A comprehensive bioinformatics software package is provided free of charge with purchase; enabling you to identify the DNA sequence, clonal prevalence, V-J family identity for each gene rearrangement, and with the IGH FR1 assay, the extent of IGHV somatic hypermutation (SHM).

VIEW AVAILABLE PRODUCTS ⟶

NEXT-GENERATION SEQUENCING (RUO)

次世代シーケンシングによるT細胞ガンマ受容体遺伝子再構成診断アッセイの有効性確認: キャピラリー電気泳動から次世代シーケンシングへの移行

marketing2021-12-29T16:36:14+00:00April 20th, 2021|2021 Publications, Publications|

Routine Evaluation of Minimal Residual Disease in Myeloma Using Next-Generation Sequencing Clonality Testing

marketing2021-02-17T18:10:07+00:00November 17th, 2020|2020 Publications, Featured Publications, Publications|

Evaluation of Somatic Hypermutation Status in Chronic Lymphocytic Leukemia (CLL) in the Era of Next Generation Sequencing

marketing2021-02-11T21:47:46+00:00May 19th, 2020|2020 Publications, Publications|

Upgraded Standardized Minimal Residual Disease Detection by Next-Generation Sequencing in Multiple Myeloma

marketing2021-02-11T21:50:38+00:00May 1st, 2020|2020 Publications, Publications|

Monitoring minimal residual disease in the bone marrow using next generation sequencing

marketing2021-02-11T22:00:56+00:00January 17th, 2020|2020 Publications, Publications|

ALL RELATED ARTICLES ⟶

NEXT-GENERATION SEQUENCING (RUO)

次世代シーケンシングによるT細胞ガンマ受容体遺伝子再構成診断アッセイの有効性確認: キャピラリー電気泳動から次世代シーケンシングへの移行

marketing2021-12-29T16:36:14+00:00April 20th, 2021|2021 Publications, Publications|

Routine Evaluation of Minimal Residual Disease in Myeloma Using Next-Generation Sequencing Clonality Testing

marketing2021-02-17T18:10:07+00:00November 17th, 2020|2020 Publications, Featured Publications, Publications|

Evaluation of Somatic Hypermutation Status in Chronic Lymphocytic Leukemia (CLL) in the Era of Next Generation Sequencing

marketing2021-02-11T21:47:46+00:00May 19th, 2020|2020 Publications, Publications|

Upgraded Standardized Minimal Residual Disease Detection by Next-Generation Sequencing in Multiple Myeloma

marketing2021-02-11T21:50:38+00:00May 1st, 2020|2020 Publications, Publications|

Monitoring minimal residual disease in the bone marrow using next generation sequencing

marketing2021-02-11T22:00:56+00:00January 17th, 2020|2020 Publications, Publications|

ALL RELATED ARTICLES ⟶

InvivoscribeのThe Laboratory for Personalized Molecular Medicine® (LabPMM®) は、患者ケアに非常に重要となる新規および自社独自のバイオマーカーについて国際的に標準化された検査を提供しています。

Lymphoma

Myeloma

Browse our comprehensive menu of product & testing services.

A proven strategy to accelerate drug approvals

Design Controls, Bioinformatics Software, Identify & Track, Custom Development, and Complementary MRD Assays

cGMP Compliant, CE-marked IVDs & CDx Manufacturing, Assay Development, and Controls & Reagents

Clinical Lab Experience, Internationally Standardized, Comprehensive Panels, Complementary MRD Assays, and Worldwide Enrollment

Accredited & Proven, Registered Medical Device Establishment, Multiple CDx Approvals, CE-marked IVDs, and Marketing Authorization Holder (MAH)

弊社は、個別化医療と質の高いヘルスケアの橋渡しをする科学の発展に誇りを持っています。

Personalized Molecular Medicine®とは、ゲノミクスと患者固有の情報を用いて、それぞれの患者に最適な治療法を特定することです。

2020年11月17日 Routine Evaluation of Minimal Residual Disease in Myeloma Using Next-Generation Sequencing Clonality Testing

2021年4月20日 Validation of a Next-Generation Sequencing-based T-Cell Receptor Gamma Gene Rearrangement Diagnostic Assay: Transitioning from Capillary Electrophoresis to Next-Generation Sequencing

2020年11月17日 Routine Evaluation of Minimal Residual Disease in Myeloma Using Next-Generation Sequencing Clonality Testing

PRODUCTS

Next-Generation Sequencing (RUO)

PRODUCTS

Next-Generation Sequencing (RUO)

Determine clonality & track clonal populations with the same reagents & workflow

Determine clonality & track clonal populations with the same reagents & workflow

NGS is a powerful, high-throughput DNA sequencing technology that allows for massively parallel sequencing of millions of DNA fragments in a single sequencing run. NGS is revolutionizing modern science and healthcare.

PATIENT INFORMATION

Why it Matters

Everyone’s disease is different.

The genetics of each individual is different. The results from these NGS tests provide important insights.

TECHNICAL INFORMATION

How it Works

Detects clonal gene rearrangements.

Our NGS kits are used to detect clonal gene rearrangements, somatic hypermutations, and for the study of MRD. These RUO products that are used extensively all over the world.

PATIENT INFORMATION

Why it Matters

Everyone’s disease is different.

The genetics of each individual is different. The results from these NGS tests provide important insights.

TECHNICAL INFORMATION

How it Works

Detects clonal gene rearrangements.

Our NGS kits are used to detect clonal gene rearrangements, somatic hypermutations, and for the study of MRD. These RUO products that are used extensively all over the world.

Illumina®

Next-Generation Sequencing

Illumina®

Next-Generation Sequencing

RUO

Invivoscribe offers an array of Research Use Only assays for use on the Illumina MiSeq®.

RUO

Invivoscribe offers an array of Research Use Only assays for use on the Illumina MiSeq®.

Thermo Fisher®

Next-Generation Sequencing

Thermo Fisher®

Next-Generation Sequencing

RUO

Invivoscribe offers an array of Research Use Only assays for use on the Ion S5™ and PGM™.

RUO

Invivoscribe offers an array of Research Use Only assays for use on the Ion S5™ and PGM™.

NEXT-GENERATION SEQUENCING (RUO)

Related Articles

NEXT-GENERATION SEQUENCING (RUO)

Related Articles

Personalized Molecular Medicine^®とは、ゲノミクスと患者固有の情報を用いて、それぞれの患者に最適な治療法を特定することです。

Next-Generation
Sequencing
(RUO)

Illumina^{^®}

Illumina^{^®}

Invivoscribe offers an array of Research Use Only assays for use on the Illumina MiSeq^®.

Invivoscribe offers an array of Research Use Only assays for use on the Illumina MiSeq^®.

Thermo Fisher^{^®}

Thermo Fisher^{^®}

Invivoscribe offers an array of Research Use Only assays for use on the Ion S5^™ and PGM^™.

Invivoscribe offers an array of Research Use Only assays for use on the Ion S5^™ and PGM^™.